Amgen Inc. is a leading global biotechnology company with an emphasis on transforming novel science into innovative medicines. The company, also known as Applied Molecular Genetics Inc, was founded in 1980 and is headquartered in Thousand Oaks, California. Its primary areas of expertise span various scientific and operational disciplines, including biology, oncology, neuroscience, nephrology, cardiovascular disease, and hematology.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative therapies. Over years, the company has built an outstanding track record of rapidly bringing safe and efficacious therapeutics to market. Amgen's product portfolio includes some of the world's best-selling drugs such as Enbrel, Prolia, Neulasta, and Aranesp.
Enbrel was for many years the world's best-selling drug to treat rheumatoid and psoriatic arthritis, and plaque psoriasis. Prolia and Aranesa are used for the treatment of osteoporosis and chronic kidney disease respectively, and Neulasta boosts white blood cells production to help cancer patients withstand chemotherapy.
On the innovation side, Amgen is one of the companies at the forefront of the genetic revolution. The company's scientists are committed to turning the advent and promise of the human genome into therapies that can dramatically improve people's lives. Amgen is also pioneering the development of a newest class of medication called biosimilars. These are cheaper versions of complex drugs called biologics, which have been derived from living cells.
In terms of financials, Amgen is one of the biggest companies in the biotechnology sector. The company is listed on the NASDAQ and is a component of the S&P 500. In 2020, it reported total revenues of $25.4 billion and a net income of $7.2 billion. The company's market capitalization is consistently above $115 billion, underscoring its dominant position in the global biopharma industry.
Amgen is not only a powerhouse in the biotechnology industry but also a recognized leader in corporate social responsibility. The company operates globally but respects and considers local needs, with initiatives aimed at improving health, education, and the environment. In summary, Amgen is a company that combines cutting-edge science with the ambition to dramatically improve the lives of patients worldwide.